Understanding Unmet Needs in the Older Acute Myeloid Leukemia (AML) Patient

E-ISSN： 1875-6301|12|4|246-252

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.12, Iss.4, 2017-05, pp. : 246-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Smoking and Risk of Acute Myeloid leukemia in Adults

By Pogoda Janice Preston-Martin Susan

Cancer Causes and Control, Vol. 17, Iss. 3, 2006-04 ,pp. : 351-352

Springer Publishing Company

Access to resources Recommend Favorite

Elacytarabine (CP-4055) in the treatment of acute myeloid leukemia

By DiNardo Courtney D O'Brien Susan Gandhi Varsha V Ravandi Farhad

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1073-1082

Future Medicine

Access to resources Recommend Favorite

Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil

By Oliveira L.

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1254-1259

Humana Press, Inc

Access to resources Recommend Favorite

Clofarabine for the treatment of adult acute myeloid leukemia

By Thomas Xavier Raffoux Emmanuel Elhamri Mohamed Lobe Ida Cannas Giovanna Dombret Hervéé

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1197-1210

Future Medicine

Access to resources Recommend Favorite

Tyrosine kinase inhibition in acute myeloid leukemia

By Altman Jessica K. Szilard Amy K. Platanias Leonidas C.

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1351-1352

Informa Healthcare

Access to resources Recommend Favorite